
Source BioScience
Diagnostic Services
Source LDPath produces cutting-edge companion diagnostic predictive and prognostic testing for cancer and other diseases. Our unparalleled combination of expertise in histopathology, coupled with the latest molecular diagnostics, enables us to provide a unique service to support specialist diagnostics.
Most popular related searches
hormone receptor
molecular diagnostic
histopathology
cancer disease
immunohistochemistry
cancer screening
- Mutation Status Testing (e.g: KRAS/EGFR/BRAF)
- NGS gene panel targeted sequencing
- Personalised Medicine testing (e.g ToxNav)
- Hormone Receptor Testing
- Routine and Specialist Immunohistochemistry Assays (IHC)
- In-situ hybridisation (ISH)
- Circulating Tumour cell assessment (CTC)